PROTO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 225
EU - Europa 189
AS - Asia 44
Totale 458
Nazione #
US - Stati Uniti d'America 225
SE - Svezia 63
IE - Irlanda 60
CN - Cina 40
FR - Francia 15
IT - Italia 13
FI - Finlandia 9
AT - Austria 8
UA - Ucraina 7
DE - Germania 6
GB - Regno Unito 4
BE - Belgio 3
IN - India 3
CZ - Repubblica Ceca 1
SG - Singapore 1
Totale 458
Città #
Dublin 59
Chandler 57
Nyköping 24
Beijing 19
Jacksonville 19
Ann Arbor 18
Dearborn 10
New York 10
Ashburn 8
Cambridge 8
Princeton 8
Vienna 8
Boardman 7
Medford 7
Des Moines 5
Woodbridge 5
Messina 4
Wilmington 4
Brussels 3
Hangzhou 3
Jinan 3
Pune 3
San Mateo 3
Zhengzhou 3
Lanzhou 2
Tianjin 2
Augusta 1
Guangzhou 1
Helsinki 1
Jiaxing 1
Kunming 1
Leawood 1
Los Angeles 1
Monmouth Junction 1
Nanjing 1
Olomouc 1
Philadelphia 1
Ratoath 1
Shenyang 1
Singapore 1
Taizhou 1
Totale 317
Nome #
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 75
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 74
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 67
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 58
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 51
New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution. 48
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 47
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 42
Totale 462
Categoria #
all - tutte 1.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 1 2 0 2 13 10 7 2 5 20 0
2020/202158 6 1 11 6 4 5 1 0 1 6 12 5
2021/202261 1 9 0 2 0 0 4 3 0 19 6 17
2022/2023184 11 22 6 12 15 25 3 13 72 0 4 1
2023/202442 1 11 4 4 3 14 3 0 0 0 1 1
2024/20251 0 1 0 0 0 0 0 0 0 0 0 0
Totale 462